David Demartini - Net Worth and Insider Trading

David Demartini Net Worth

The estimated net worth of David Demartini is at least $175,411 dollars as of 2024-05-22. David Demartini is the Director of Lexaria Bioscience Corp and owns about 58,666 shares of Lexaria Bioscience Corp (LEXX) stock worth over $175,411. Details can be seen in David Demartini's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Demartini has not made any transactions after 2010-08-30 and currently still holds the listed stock(s).

Transaction Summary of David Demartini

To

David Demartini Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Demartini owns 1 companies in total, including Lexaria Bioscience Corp (LEXX) .

Click here to see the complete history of David Demartini’s form 4 insider trades.

Insider Ownership Summary of David Demartini

Ticker Comapny Transaction Date Type of Owner
LEXX Lexaria Bioscience Corp 2010-08-30 director & 10 percent owner

David Demartini Latest Holdings Summary

David Demartini currently owns a total of 1 stock. David Demartini owns 58,666 shares of Lexaria Bioscience Corp (LEXX) as of August 30, 2010, with a value of $175,411.

Latest Holdings of David Demartini

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LEXX Lexaria Bioscience Corp 2010-08-30 58,666 2.99 175,411

Holding Weightings of David Demartini


David Demartini Form 4 Trading Tracker

According to the SEC Form 4 filings, David Demartini has made a total of 0 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 917 shares on August 30, 2010, which cost David Demartini around $4,500.

Insider Trading History of David Demartini

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Demartini Trading Performance

GuruFocus tracks the stock performance after each of David Demartini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Demartini is 22.22%. GuruFocus also compares David Demartini's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Demartini within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Demartini's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Demartini

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 47.22
Relative Return to S&P 500(%) 38.42

David Demartini Ownership Network

Ownership Network List of David Demartini

No Data

Ownership Network Relation of David Demartini


David Demartini Owned Company Details

What does Lexaria Bioscience Corp do?

Who are the key executives at Lexaria Bioscience Corp?

David Demartini is the director & 10 percent owner of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Chief Financial Officer Gregory Downey , director & 10 percent owner & CEO Christopher Bunka , and Secretary Vanessa Carle .

Lexaria Bioscience Corp (LEXX) Insider Trades Summary

Over the past 18 months, David Demartini made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net purchase of 1,500 shares made by Catherine C. Turkel ,

In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.

Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexaria Bioscience Corp Insider Transactions

No Available Data

David Demartini Mailing Address

Above is the net worth, insider trading, and ownership report for David Demartini. You might contact David Demartini via mailing address: 11714 Spriggs Way, Houston Tx 77024.

Discussions on David Demartini

No discussions yet.